ciprofloxacin has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oteo, JA | 1 |
| Castilla, A | 1 |
| Arosey, A | 1 |
| Blanco, JR | 1 |
| Ibarra, V | 1 |
| Morano, LE | 1 |
1 review available for ciprofloxacin and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
[Endocarditis due to Bartonella spp. Three new clinical cases and Spanish literature review].
Topics: Actinobacillus Infections; Adult; Aged; Aggregatibacter actinomycetemcomitans; Alcoholism; Animals; | 2006 |